drugset / Trial / NCT03855267

Etomidate/Propofol Mixture or Propofol Monotherapy Use in Patients Undergoing General Anesthesia

NCT03855267

Unknown 200 enrolled Guolin Wang
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study was to investigate the effects of different proportions of etomidate/propofol mixture and propofol alone intravenous anesthesia on intraoperative and postoperative physiological indicators and complications, and to find out the optimal use ratio of E/P mixture.

Timeline

Start
2019-01-01
Primary completion
2019-10-31
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule 2 mg/ml Intravenous
Comparator Propofol Small molecule 20 mg/ml Intravenous

Indications

No indication recorded.